KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
$25.77
0.00%
(0.00) 1D
Mar 13, 11:45:41 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KSPHF...
Mkt. cap
178.26B
Avg. vol.
0.00
Volume
0.00
52-wk high
$31.90
52-wk low
$25.10
Beta
13.91
Shares outstanding
46.54M
No. of employees
2K
Mkt. cap
178.26B
Avg. vol.
0.00
Volume
0.00
52-wk high
$31.90
52-wk low
$25.10
Beta
13.91
Shares outstanding
46.54M
No. of employees
2K
News stories
From web sources and news partners
www.marketscreener.com
·
39 minutes ago
Mizuho Lowers Price Target on Dow to $32 From $35, Keeps Neutral Rating
Barron's
·
28 minutes ago
S&P 500 Futures Climb in Premarket Trading; Corteva, Sun Life Financial Lag
24/7 Wall St.
·
28 minutes ago
Every S&P Sector Fell in September Except One
TradingView
·
2 hours ago
Dow futures hit three-month low as yields surge, Micron earnings offer support
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1.79K
FoundedAug 9, 1946
HeadquartersMatsumoto, Nagano, Japan
SectorPharmaceutical industry
Websitekissei.co.jp